Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vimab Group AB's EBIT per Share for the
three
months ended in Mar. 2026 was kr-0.42.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr-2.41.
During the past 3 years, the average EBIT per Share Growth Rate was -23.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Vimab Group AB's EBIT per Share or its related term are showing as below:
OSTO:VIMAB'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -74.5 Med: -11.6 Max: 167.5
Current: -23.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Vimab Group AB was 167.50% per year. The lowest was -74.50% per year. And the median was -11.60% per year.
OSTO:VIMAB's 3-Year EBIT Growth Rate is ranked worse than 86.81% of 849
companies
in the Business Services industry
Industry Median: 8
vs OSTO:VIMAB: -23.40
Vimab Group AB's EBIT for the
three
months ended in Mar. 2026 was kr-18.4 Mil.
Vimab Group AB (OSTO:VIMAB) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Vimab Group AB EBIT per Share Related Terms
Vimab Group AB EBIT per Share Historical Data
* Premium members only.
The historical data trend for Vimab Group AB's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-2.41
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vimab Group AB (OSTO:VIMAB) has a EBIT per Share of kr-2.41 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vimab Group AB and its competitors. According to the industry distribution chart, Vimab Group AB ranks #737 out of 849 companies in the Business Services industry, placing it in the top 86.8%.
Is Vimab Group AB's EBIT per Share too high?
Vimab Group AB's current EBIT per Share is kr-2.41. Based on the distribution chart, Vimab Group AB ranks #737 out of 849 companies in the Business Services industry, which is in the bottom quartile relative to peers. Overall, Vimab Group AB has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vimab Group AB's EBIT per Share compare to VRSK and EFX?
According to the Business Services industry distribution chart, Vimab Group AB ranks #737 out of 849 companies for EBIT per Share. This places Vimab Group AB in the lower half of its industry. The industry median EBIT per Share is 8.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Business Services company?
The median EBIT per Share among Business Services companies is 8.00, based on 849 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vimab Group AB and its competitors. For the Business Services industry, the median EBIT per Share is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimab Group AB's current EBIT per Share is kr-2.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimab Group AB stock overvalued right now?
Based on GuruFocus' analysis, Vimab Group AB (OSTO:VIMAB) is currently considered Possible Value Trap. The stock's GF Value™ is kr6.01, compared to a current price of kr2.97 — trading 50.6% below its estimated fair value. The current EBIT per Share is kr-2.41. Vimab Group AB's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Vimab Group AB (OSTO:VIMAB), the current EBIT per Share is kr-2.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vimab Group AB (OSTO:VIMAB) Overvalued in 2026?
Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued.
The current stock price of kr2.97 is trading 50.6% below its estimated GF Value™ of kr6.01.
GuruFocus considers Vimab Group AB to be Possible Value Trap.
Key valuation signals for OSTO:VIMAB:
EBIT per Share: kr-2.41
GF Value™: kr6.01 vs. price of kr2.97 (50.6% below fair value)
No single metric tells the full story. See the OSTO:VIMAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
51GF Score
Get the complete analysis for OSTO:VIMAB
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:VIMAB has been successfully added to your 
